Table 2 Summary of real-world data from a retrospective analysis of cohorts comprising at least four patients.

From: Voretigene neparvovec for inherited retinal dystrophy due to RPE65 mutations: a scoping review of eligibility and treatment challenges from clinical trials to real practice

Authors, Year, Ref

Study design

Patient N, age range

Baseline characteristics

Follow up time

Main findings

Stingl et al. [27]

Single centre

5; 14–36 years

Patient’s eligibility to treatment in accordance with the German Society of Ophthalmology recommendations

Clinical diagnosis: EOSRD;

BCVA (decimal) range FC-0.2;

FST blue average (dB): −3.39;

FST red average (dB); 0.83;

DAC blue average (dB): −2.91;

DAC red average (dB): −1.01;

CPC rods average (relMCA): 0.31; CPC cones average (relMCA): 4.12

3 months

VA improved or remained stable in all eyes

Age as strong prediction factor with respect to blue light FST gain and the average of the DAC stimuli (cyan) and moderate with respect to the increase of the average macular scotopic CPC response

Local retinal volume as a moderate predictor with respect to scotopic CPC response

The improvement in the rod function (by CPC) depended on patients’ age and remaining retinal thickness

Sengillo et al. [16]

Multicentre

41; 2–44 years

Paediatric eyes mean BCVA 20/150 (20/40-CF);

adult eyes mean BCVA 20/260 (20/70-LP);

mean CFTs: 210 mm and 176 mm in paediatric and adult patients, respectively

Mean white light FST score: 0.6 ± 3.7 dB

Mean 10 months (range 1 week–18.5 months)

3/4 of eyes remained within one line of baseline BCVA. No significant difference in the mean BCVA changes in adult vs paediatric eyes. Baseline VA did not affect postoperative acuity changes

BCVA change from baseline in eyes with and without foveal detachment: no significant difference at follow-ups

Mild thinning in mean CFT both in paediatric and adult eyes regardless of intraoperative foveal detachment or age

FST mean improvement of 21.1 ± 16.6 dB

Deng et al.[17]

Single centre

14; 4–17 years

Mean FST: −2.0 log cd.s/m2

Mean CST: 215 μm (range: 192–247)

Mean VA: log- MAR 0.98 (range 0.40–1.70; Snellen equivalent, 20/191)

Median 513 days (167–677 days)

Significant improvements in FST, expansion of III4e isopter, BCVA

Significant decrease in mean CST

Sub-foveal ONL thickness stable over time

Testa et al.[39]

Single centre

6; 7–17

Mean BCVA: 0.70 ± 0.08 logMAR

(Snellen equivalent of 20/100)

Reduced central foveal retinal thickness, central foveal ONL

thickness and mean ONL thickness of the internal ETDRS ring compared to age-matched healthy eyes

6 months

Significant change in VA and increase of ONL thickness in the internal ETDRS ring

BCVA change positively associated with ONL thickness increase in the internal ETDRS ring

BCVA improved irrespective of intra-operative foveal detachment

Central foveal ONL thickness decrease associated with intra-operative foveal detachment.

ONL thickness of the internal ETDRS ring change not associated with intra-operative foveal detachment

Gerhardt et al. [38]

Single centre

4; 3–6 years

Clinical diagnosis: LCA

BCVA range: 1.3–0.7 logMAR.

Nystagmus

Lack of 488 nm autofluorescence in all patients

Mobility test failed below 40 lux.

III/4 isopter in Goldmann VF testing: not disclosed

ERGs and 30 Hz flicker ERGs unrecordable

FST reliable in one patient (−9.5 dB)

Mean 18.5 months

Statistically and clinically significant VA improvement at month 6

Damped or amplitude reduced nystagmus

Mobility test passed at 4 lux

Measurable III4e isopter in three patients

Post treatment flicker ERGs recordable in two patients

Post-treatment FST measured in two patients and remarkably improved by at least 30 dB in each eye at month 6

  1. BCVA best corrected visual acuity, CPC chromatic pupil campimetry, CRT central retinal thickness, CST central subfield thickness, DAC dark-adapted chromatic perimeter, ETDRS Early Treatment of Diabetic Retinopathy Study, FST full-field sensitivity threshold, LogMAR logarithm of Minimum Angle of Resolution, ONL outer nuclear layer, relMCA relative maximal constriction amplitude, VA visual acuity, VF visual field.